CoChat

Aβ and tau structure‐based biomarkers for a blood‐ and CSF‐based two‐step recruitment strategy to identify patients with dementia due to Alzheimer's disease

Open access
Nabers, Andreas, Hafermann, Henning, Wiltfang, Jens, Gerwert, Klaus · 2019 · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
Cited by 48

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Abstract

Introduction: Alzheimer's disease (AD) diagnosis requires invasive CSF analysis or expensive brain imaging. Therefore, a minimal‐invasive reliable and cost‐effective blood test is requested to power large clinical AD trials at reduced screening failure. Methods: We applied an immuno‐infrared sensor to measure the amyloid‐β (Aβ) and tau secondary structure distribution in plasma and CSF as structure‐based biomarkers for AD (61 disease controls, 39 AD cases). Results: Within a first diagnostic screening step, the structure‐based Aβ blood biomarker supports AD identification with a sensitivity of 90%. In a second diagnostic validation step, the combined use of the structure‐based CSF biomarkers Aβ and tau excluded false‐positive cases which offers an overall specificity of 97%. Discussion: The primary Aβ‐based blood biomarker funnels individuals with suspected AD for subsequent validation of the diagnosis by structure‐based combined analysis of the CSF biomarkers Aβ and tau. Our novel two‐step recruitment strategy substantiates the diagnosis of AD with a likelihood of 29.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.dadm.2019.01.008

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 14 references

Cited by

See all 48

Metadata

Authors
Nabers, A., Hafermann, H., Wiltfang, J., & Gerwert, K.
Venue
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
Publisher
Wiley
Published
2019-03-12
Volume
11
Issue
1
Pages
257-263
ISSN
2352-8729 (ISSN-L)
OpenAlex
W2947894924
Cited by
48
References
14
FWCI
4.86
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Aβ and tau structure‐based biomarkers for a blood‐ and CSF‐based two‐step recruitment strategy to identify patients with dementia due to Alzheimer's disease. https://app.cochat.ai/papers/10.1016/j.dadm.2019.01.008
The paper
Nabers, A., Hafermann, H., Wiltfang, J., & Gerwert, K. (2019). Aβ and tau structure‐based biomarkers for a blood‐ and CSF‐based two‐step recruitment strategy to identify patients with dementia due to Alzheimer's disease. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring. https://doi.org/10.1016/j.dadm.2019.01.008

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.